Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AP4B1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CEP97 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | RPL7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | POU3F1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | PLRG1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
mRNA | AGL | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | SPSB2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | EMP3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CDH13 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CTF1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |